GOODMAN NOAH (Chief Business Officer) sold 9.1% of their position (5K shares) of KYMERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $570.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/25/2026ACC: 0001193125-26-283139
Officer· Chief Business Officer
Since Mar 2026
-5K
Net shares
Net seller
$570.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5K
Price / share
$21.05
Trade value
$105.25K
% of position
10.0%
6/25/2026
50.20K→55.20K
Common Stock
Direct
Shares
−2.50K
Price / share
$109.00
Trade value
$272.50K
% of position
4.5%
6/25/2026
55.20K→52.70K
Common Stock
Direct
Shares
−2.50K
Price / share
$119.00
Trade value
$297.50K
% of position
4.7%
6/25/2026
52.70K→50.20K
Total
Net shares
+0.00
Net value
-$464.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2026 | M · Option Exercise | +5K | $21.05 | $105.25K | 10.0% | 50.20K | 55.20K |
| Common Stock Direct | 6/25/2026 | S · Sale | −2.50K | $109.00 | $272.50K | 4.5% | 55.20K | 52.70K |
| Common Stock Direct | 6/25/2026 | S · Sale | −2.50K | $119.00 | $297.50K | 4.7% | 52.70K | 50.20K |
| Total | +0.00 | -$464.75K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
21.05
Held after
90K
Exercisable
—
6/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 6/25/2026 | M · Option Exercise | −5K | 21.05 | — | 90K |